HIGHFDA DRUG

Lannett NIACIN ER 1,000 mg Recall Affects 46,848 Bottles Nationwide (2025)

Lannett Company, Inc. recalled 46,848 bottles of NIACIN Extended-release Tablets, 1,000 mg, Rx Only, distributed nationwide. The product failed dissolution specifications. Patients and healthcare providers should stop using it immediately and await recall instructions.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
October 10, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
October 10, 2025
Hazard Level
HIGH
Brands
Lannett, NIACIN
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Lannett, NIACIN
Product type
Extended-release Niacin Tablet 1000 mg
Model numbers
21264027A, 22266446A, 22266901A, 22267553A, 22267554A, 22267555A, 22267992A, 22267993A +1 more
UPC codes
62175-320, 62175-322, 62175-320-46, 62175-320-43, 62175-322-46, 62175-322-43
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    October 10, 2025

  2. Reported by FDA DRUG

    October 29, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed Dissolution Specifications

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Lannett Company Inc. or your healthcare provider for guidance. Notification method: Letter

About This Product

NIACIN Extended-release tablets are a prescription-grade form of vitamin B3 used to treat cholesterol and other conditions under medical supervision. The product discussed is 1,000 mg per tablet and distributed nationwide in 90-tablet bottles.

Why This Is Dangerous

The dissolution failure means the tablet may not dissolve properly in the stomach, potentially reducing therapeutic effect and leading to ineffective treatment.

Industry Context

This recall is not stated as part of a broader industry pattern.

Real-World Impact

Consumers may require alternatives or adjustments to therapy. The recall impacts patients relying on prescribed Niacin ER without assurance of dissolution performance until guidance is provided.

Practical Guidance

How to identify if yours is affected

  1. 1. Locate NDC 62175-322-46 on your NIACIN bottle.
  2. 3. Review expiration dates: 10/30/2025 onward through 05/31/2026.
  3. 4. If your bottle matches any of these identifiers, stop using it and contact the manufacturer for guidance.

Where to find product info

Label on the bottle shows NDC, lot number, and expiration date. The official recall notice will provide refund or replacement instructions.

What timeline to expect

Refunds or replacements are typically processed within 4-8 weeks after proof of purchase or return is received.

If the manufacturer is unresponsive

  • Document all contact attempts with the manufacturer.
  • File a complaint with the FDA if the company does not respond within a reasonable time.
  • Consider legal counsel if significant injuries or losses occur and the company remains unresponsive.

How to prevent similar issues

  • Always verify NDC and lot numbers when receiving prescription medications.
  • Compare recall numbers with FDA notices and maintain a record of batch information.
  • Ask pharmacists about safety alerts when starting or continuing therapy.

Documentation advice

Keep the original bottle, packaging, and recall notice. Photograph the label showing NDC, lot, and expiration. Save receipts and correspondence with the manufacturer.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

NDC: 62175-322-46. Pack: 90 tablets per bottle. Quantity recalled: 46,848 bottles. Distribution: Nationwide in the USA. Sold as NIACIN Extended-release Tablets, 1,000 mg, Rx Only. Lot numbers and expirations include: 21264027A Exp 10/30/2025; 22266446A Exp 12/31/2025; 22266901A Exp 02/28/2026; 22267553A Exp 03/31/2026; 22267554A Exp 02/28/2026; 22267555A Exp 02/28/2026; 22267992A Exp 04/30/2026; 22267993A; 22267994A Exp 05/31/2026.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Expiry dates: 10/30/2025 to 05/31/2026

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
21264027A
22266446A
22266901A
22267553A
22267554A
+4 more
UPC Codes
62175-320
62175-322
62175-320-46
+3 more
Affected States
ALL
Report Date
October 29, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more